Form 4 for TNYA Tenaya Therapeutics, Inc.
Accepted 2022-04-28 00:00:00 ET · period of report 2022-04-26 · accession 0001209191-22-026097 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-04-28 | 2022-04-26 | TNYA | Hoey Timothy | CSO | S - Sale | $10.13 | -1,353 | 198.6K | -0.7% | -$13.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-26 | S | D | 1,353 | $10.13 | 198,646 | D | — | — | (F2) Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $10.02 to $10.33. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. |